Rationale: CD4 T cells are involved in the pathogenesis of atherosclerosis, but atherosclerosis-specific CD4 T cells have not been described. Moreover, the chemokine(s) that regulates T-cell trafficking to the atherosclerotic lesions is also unknown. 
A therosclerosis is caused by accumulation of low-density lipoprotein in the intima of large arteries, leading to infiltration by monocytes. Atherosclerosis has long been known to have an immune component that modulates plaque burden and disease progression. [1] [2] [3] [4] CD4 T cells are the most abundant adaptive immune cells in atherosclerotic plaque in humans [5] [6] [7] and mice. 8 Many plaque CD4 T cells secrete interferon-γ (IFN-γ), 9 a T helper 1 (Th1) proinflammatory cytokine that is known to advance atherosclerosis. 10 The defining transcription factor of these IFN-γ-secreting Th1 cells is T-bet. 11 Some CD4 T cells in atherosclerotic plaques have been described to express FoxP3, the defining transcription factor of regulatory T cells (Tregs). 3, 12 Tregs are thought to be atheroprotective, [13] [14] [15] [16] but there is evidence that the number of Tregs declines as atherosclerosis progresses. [17] [18] [19] [20] In This Issue, see p 1453
Editorial, see p 1461
CD4 T cells are found in atherosclerotic plaque, but it is not clear how they get there. Adoptive transfer experiments have shown that naive CD4 T cells use L-selectin to home to the adventitia of normal and atherosclerotic mice. 21 However, most CD4 T cells in atherosclerotic plaque are not naive but have an effector phenotype and interact with antigen-presenting cells. 9, 22 In a previous study from this laboratory, we showed that the chemokine receptor CXCR6 is required for the homing of a small subset of T cells. 23 Other candidate chemokine receptors that could be responsible for Th1-cell homing are CXCR3 and CCR5. CXCR3 has been shown to be responsible for T-cell homing in airway inflammation 24 and adipose tissue 25 inflammation in an obesity model. Although CCR5 is known to be involved in atherosclerosis and recruitment of classical monocytes, 26, 27 its potential role in T-cell homing to atherosclerotic arteries has not been studied.
On the basis of initial findings that CCR5 but not CXCR3 was expressed on many T cells found in atherosclerotic arteries, we focused on CCR5 and its ligand CCL5. CCR5 is expressed on monocytes, macrophages, and Th1 cells. 26 Classical monocytes (Ly-6C hi in mice) use CCR5 (among other chemokine receptors) to reach atherosclerotic lesions. 28, 29 Its ligand CCL5 is expressed by monocytes, macrophages, smooth muscle cells, and platelets. Platelets can deposit CCL5 on the endothelial surface and promote arrest (adhesion) from rolling. 30, 31 Genetic deletion studies in Apoe −/− mice suggest that CCR5 has a proatherogenic role in neointimal plaque formation. Ccr5 −/− Apoe −/− mice are protected from diet-induced atherosclerosis and show a more stable plaque phenotype, reduced mononuclear cell infiltration, reduced T-cell infiltration, reduced Th1-type immune responses, and increased interleukin (IL)-10 expression. 26, 32 TAK-779, an inhibitor of both CCR5 and CXCR3, dramatically reduced atherosclerosis in the aortic root and carotid arteries of Ldlr −/− mice. The number of T cells in the plaque was reduced by 95%, concurrently with a 98% reduction in area staining for IFN-γ, 33 suggesting a role of CCR5 and CXCR3 in regulating Th1-cell homing to the aorta. CCL5 antagonist treatment in Ldlr −/− mice similarly inhibited progression of established atherosclerosis and decreased CD4 T-cell infiltration in the aorta. 30, 34 However, studies with global knockout or inhibition of CCR5 cannot address the role of CCR5 in T-cell homing because CCR5 is broadly expressed.
The present study was designed to investigate mechanisms of T-cell homing to atherosclerotic arteries using ex vivo and in vivo adoptive transfer systems analyzed by flow cytometry, confocal immunofluorescence, and multiphoton microscopy. In the course of these experiments, we discovered that almost all CCR5 + T cells express FoxP3, T-bet, and IFN-γ. Effector T-cell (Teff) proliferation assays show that these FoxP3 + T-bet + IFN-γ + T cells lack the ability to regulate Teff proliferation. Adoptive transfer of CCR5 + CD4 T cells significantly increases atherosclerosis.
Methods
An expanded Methods section is available in the Online Data Supplement.
In Vitro T-Cell Homing Assay
The aortic arch, the thoracic aorta, and part of the abdominal aorta (above the renal arteries) were surgically removed from Apoe −/− Western diet (WD) mice. All para-aortic lymph nodes (paLNs) and adipose tissue were carefully removed without disturbing the aortic wall itself. 
In Vivo T-Cell Homing Assay
Splenocytes from Ccr5 −/− Apoe −/− WD mice and dsRedApoe −/− mice were harvested, and red blood cells were lyzed (eBioscience). The leukocytes were mixed 1:1 ratio, and 60 million cells were injected retro-orbitally into each recipient CD45.1Apoe −/− WD mice. Twentyfour hours later, the recipient mice were euthanized, and aorta, paLNs, spleen, blood, inguinal lymph nodes, and axillary lymph nodes were harvested. The aortas were digested as described. 22 Cells were analyzed by flow cytometry. The percentage of each recovered population was normalized to the percentage in the input mix.
Results

T Cells in the Aorta of Apoe −/− WD Mice Express CCR5
Aortas from Apoe −/− mice on WD for 3 to 5 months were digested as described 21, 22 and prepared for flow cytometry. In all experiments, leukocytes were identified by CD45 expression and dead cells were excluded ( Figure 1A ). Cells were gated for singlets by forward scatter impulse width and side scatter impulse width (not shown). Because CD4 expressed on the T-cell surface is lost after the aorta digestion process (Online Figure I) , we detected T cells in the aorta by antibodies against TCRβ and CD8. αβ-T cells as detected by staining for TCRβ ( Figure 1B ) accounted for 18% to 40% of all live CD45 + singlets. We focused on CCR5 because this chemokine receptor was highly and reproducibly induced in aortic αβ-T cells of Apoe −/− mice on WD ( Figure 1C ) but not in control mice. The appearance of CCR5 + T cells correlated with the duration of WD and peaked at 5 months (Online Figure II) . CD8 + αβ-T cells did not express CCR5 (data not shown). αβ-T cells in aortas of Apoe −/− mice on chow diet (CD) or wild-type C57BL/6 mice expressed low levels of CCR5 ( Figure 1C ). Interestingly, these cells expressed no CXCR3 ( Figure 1D ; positive control in Online Figure III) . A subset of about 1% to 10% of aortic T cells in Apoe −/− mice on WD, but not on CD, expressed CXCR6 ( Figure 1E ), which is similar to findings in a previous report. 23 A much larger percentage (43%±6%) of aortic αβ-T cells expressed CCR5 ( Figure 1C and 1F) . This was significantly higher than the fraction of CCR5-expressing αβ-T cells in aortas of wild-type C57BL/6 mice (10%±7%) or in Apoe −/− mice on CD (7%±6%). We found some CCR5 + CD4
+ T cells in the draining paLNs and the spleen, but this fraction did not increase significantly in Apoe −/− mice on CD or WD (Online Figure IV) . To assess the localization of CCR5 + T cells, we stained aortic root sections from Apoe −/− mice for CCR5 and CD3. As expected, we found many more CCR5 + than CD3 + cells (Figure 2A-2E ). This is consistent with the known expression of CCR5 on myeloid cells. Almost all CD3 + T cells also expressed CCR5 and localized in the atherosclerotic lesions near the lumen ( Figure 2E ). The negative control for CCR5 is shown in Figure 2F . The main ligand for CCR5 is CCL5 (RANTES [regulated on activation, normal T cell expressed and secreted]). 35 Immunostaining aortic roots for CCL5 was Isotype control for CCL5 is shown in Figure 2K .
CCR5 and its Ligand CCL5 Regulate T-Cell Homing to the Atherosclerotic Aorta
Because almost half of aortic T cells expressed CCR5 ( Figure 1F ) and CCL5 was abundantly found in lesions ( Figure 2G ), we reasoned that CCL5 and CCR5 might be involved in homing of antigen-experienced CD4 T cells to atherosclerotic lesions. To test this, we used 3 assays: T-cell infiltration into the explanted aorta, multiphoton microscopy, 22 and competitive homing. 37 Explanted aortas harvested from Apoe −/− mice were incubated overnight with effector CD4 T cells (CD44 Figure 3A) . Among the TCRβ + T cells recovered from each explanted aorta, ≈80% (≈1000 cells) were donor derived, with the balance being CD45.2 + (host derived; Figure 3A , right). Pretreating the T cells with a blocking monoclonal antibody to CCL5 reduced the infiltration by >50% ( Figure 3A , bar graph). Similar effects were seen with a blocking monoclonal antibody to CCR5. The combined blockade of CCL5 and CCR5 had no additional effect, suggesting that CCL5 acted on CCR5 to attract these cells into the vessel wall. Also, treating the T cells with pertussis toxin to block signaling through all Gαi-coupled chemokine receptors had the same effect. These findings suggest that the CCL5-CCR5 pathway is the major receptor-ligand pair driving CD4 T cells into the aortic tissue. Consistent with the finding that not all aortic T cells expressed CCR5, there was residual T-cell infiltration into aortas even when CCR5, CCL5, both, or all chemokine receptors were blocked, and this background level was similar to that of naive T cells (CD44 lo CD62L + : Figure 3A , last bar in the bar graph). To directly test whether CCR5 was involved in T-cell homing to the aorta in vivo, we adoptively transferred splenocytes from Apoe 
Ccr5
−/− cells when compared with dsRedApoe −/− ( Figure 3B ). As a negative control, we investigated inguinal lymph nodes ( Figure 3B ) as well as other lymphoid organs (Online Figure  VI) by flow cytometry and found no effect of the absence of CCR5 on the homing of CD4 T cells or all leukocytes, as expected. These in vivo data show that CD4 T cells uniquely depend on CCR5 and its ligand CCL5 for their homing to the atherosclerotic aorta.
To obtain a visual representation of the proximity of T cells to antigen-presenting cells, we investigated aortas from CD11c-YFP Apoe −/− mice 22 incubated with labeled Teffs by multiphoton microscopy ( Figure 3C , i-iv). We found that untreated T cells infiltrated the explanted aortas and reached the YFP + antigen-presenting cells ( Figure 3C , ii). This infiltration was abolished by pretreatment with anti-CCL5 ( Figure 3C , iv). Taken together, flow cytometry, in vivo competitive homing, and ex vivo imaging results all show that CCL5 and its receptor CCR5 are required for CD4 T-cell homing to atherosclerotic mouse aortas.
Flow Cytometry of CCR5 + CD4 T Cells in the Aorta and paLNs of Apoe −/− WD Mice
Aortas of Apoe −/− mice 38 and humans 39 are known to contain CD4 T cells and a smaller number of CD8 T cells. Most of these T cells express IFN-γ, identifying them as Th1 cells. 9 A smaller subset of CD4 T cells express FoxP3, 16 a transcription factor found in Tregs. 40 , 41 When we interrogated αβ-T Figure 4 is less than that shown in Figure 1 because permeabilization reduced the detectable CCR5 on T-cell surface (Online Figure VII) .
The abdominal aorta is drained by the paLNs. We reasoned that Teffs may traffic from the aorta to its draining lymph nodes (and back). Therefore, we tested αβ-T cells in paLNs for the expression of CCR5. Indeed, we found that a subset (≈2.5% of all αβ-T cells) expressed CCR5. Among the CCR5 + T cells, we found both − αβ-T cells in the paLNs, we found a substantial number of FoxP3 + IFN-γ − cells that did not express T-bet. These cells were mixed for CD44 and CD62L, and some expressed CD25 ( Figure 4B, bottom) . This is consistent with the phenotype of Tregs. Among the few CCR5 + αβ-T cells found in spleens of Apoe −/− mice on WD, no FoxP3 + IFN-γ + T-bet + cells were found (Online Figure VIII) . In the aortas of Apoe −/− mice on WD, >80% of all CCR5 + αβ-T cells expressed FoxP3 and IFN-γ. This fraction was still >15% in paLNs ( Figure 4E ), but FoxP3
+ IFN-γ + T cells were undetectable in the spleen. Taken together, these data show that the CCR5Teff cells are concentrated in the aorta, with some making their way to the paLNs but not (at detectable levels) to the spleen. We emphasize that, as in previous studies, 42 we find that the spleen does not reflect the lymphocyte composition of the aorta.
CCR5Teff Do Not Suppress T-Cell Proliferation
To test the functionality of the newly discovered atherosclerosis-specific T-cell subset, we conducted an in vitro Treg assay. As positive controls, we used conventional Tregs sorted from FoxP3-GFP Apoe −/− mice 43, 44 on WD for 5 months (Online Figure IX) Figure 5A ). However, the CD4 + CCR5 + cells from paLNs were completely unable to suppress Teff proliferation at any ratio, including 1:1 ( Figure 5A and 5B). Although CCR5Teff cells did not inhibit T-cell proliferation, they did inhibit T-cell cytokine secretion ( Figure 5C ). When cultured at 1:1 or 2:1 ratios to T cells, CCR5Teff cells significantly decreased IFN-γ, IL-4, IL-13, IL-6, and IL17A secretion but not IL-2 or IL-5. At the 2:1 ratio, they also reduced IL-10 and tumor necrosis factor (TNF) secretion. However, in all cases, the suppressive effect of the CCR5Teffs is less than that of Tregs. The finding that CCR5Teff cannot suppress IL-2 secretion probably explains why CCR5Teff cells are completely unable to suppress Teff proliferation ( Figure 5A and 5B).
Transcriptomic Analysis Shows That CCR5Teff Is Similar to Teff
To analyze genome-wide CCR5Teff cell gene expression, we performed RNA sequencing using sorted CCR5Teff, Treg, and Teff from the paLNs from Apoe −/− mice on WD for >5 months. We found only 23 genes that were significantly differentially expressed in CCR5Teff versus Teff, whereas 780 genes were differentially expressed between CCR5Teff and Treg ( Figure  6 ; Online Table I ). This result confirms the functional result ( Figure 5 ) that CCR5Teffs are similar to Teff but not to Treg. The similarity between CCR5Teff and Teff was confirmed by heatmap and principal component analysis ( Figure 6B and 6C). Although CCR5Teffs express FoxP3 as seen by flow cytometry, real-time polymerase chain reaction and confirmed by RNA sequencing, their read counts reflecting FoxP3 mRNA are much lower than in Tregs ( Figure 4D ). They express more T-bet and IFN-γ than Tregs ( Figure 4D ). These findings suggest that CCR5Teffs are not regulatory and may play a pathogenic role in the pathogenesis of atherosclerosis.
Adoptive Transfer
To test the functionality of the newly discovered CCR5Teff T-cell subset in vivo, we adoptively transferred sorted CCR5 
Apoe
−/− WD mice and quantified aortic plaque area of the recipients 12 weeks after adoptive transfer. The mice that received CCR5Teff showed significantly increased plaque area in the whole aorta and thoracic aorta compared to mice that received CCR5 − Teffs ( Figure 7A and 7B), and transferred CCR5 + T cells were detected in the aortic roots by immunofluorescence indicated by white arrows (Figure 7C and 7D). Flow cytometry analysis of the carotid arteries, blood, paLNs, and spleen of the recipient mice showed that CCR5Teff cells preferentially homed to the carotid arteries ( Figure 7E ). Cytometric bead array analysis of sorted cells showed that the cytokine production profile of the CCR5Teff T-cell subset is more similar to the Teffs than the Tregs. CCR5Teff cells produce high levels of IFN-γ, TNF-α, IL-10, and IL-2 but not IL-5, IL-6, IL-13, or IL-17 after stimulation ( Figure 7F ). IFN-γ and TNF are known proatherogenic cytokines. 9, 10, 45, 46 Although M1 macrophage markers, such as inducible nitric oxide synthase and CD11c, are not increased in the aorta root of mice received CCR5Teff (Online Figure X) , high expression of IFN-γ and TNF at mRNA and protein level suggests that the CCR5Teff T cells promote atherosclerosis by secreting these cytokines.
Discussion
Here, we report that CCR5 and its ligand CCL5 are major chemokine receptor-ligand pairs required for CD4 T-cell homing to Although previous studies had shown that blocking CCR5 was protective, 33, 47 our data are the first to unequivocally establish CCR5 as the major homing receptor for CD4 T cells into atherosclerotic lesions in Apoe −/− mice. A previous study from this laboratory has shown that effector CD4 T cells (CD44 hi CD62L lo ) are present in atherosclerotic but not in control mice. 22 These cells can interact with CD11c + antigen-presenting cells in the aortic wall in an major histocompatibility complex-II-restricted manner without adding exogenous antigen. Therefore, atherosclerosis antigens are present in the diseased but not in the normal aorta, and their presentation induces a recall response with production of IFN-γ and TNF. 22 However, the phenotype of endogenous CD4 T cells was not analyzed beyond CD44 and CD62L in that study. It is likely that the aorta-homing T cells described here are the producers of IFN-γ seen elsewhere. 22 IFN-γ is known to drive atherosclerosis. 9, 10, 48 FoxP3 is considered the lineage-defining transcription factor for Tregs. 40, 49 Recently, subsets of Tregs have been described that express FoxP3 and T-bet (for Th1) or GATA3 (trans-acting T-cell-specific transcription factor; for Th2) or ROR-γt (retinoic acid receptor-related orphan receptor; for Th17) or Bcl6 (for TFH). [50] [51] [52] [53] [54] T-bet + FoxP3 + CD4 cells have been called Th1-like Treg. Although Th1-likeTregs can produce IFN-γ, they retain the capacity to regulate Teff expansion in the standard in vitro suppression assay. 51, 54 In the present study, the absence of suppressive activity of CCR5Teff formally rules out the possibility that the CCR5Teff cells found in atherosclerotic aortas and paLNs are Th1-like Tregs as described. [54] [55] [56] [57] [58] This leaves 2 possibilities: the CCR5Teff cells could be ex-Tregs that have lost (most) FoxP3 expression and the ability to regulate, or they could be Teffs that transiently express (some) FoxP3.
That FoxP3 is not only expressed in Tregs was discovered by Walker et al. 59 FoxP3 can be expressed in human CD4 + CD25
− T cells, a population that is not thought to contain Tregs. This was confirmed in another study, 60 suggesting that FoxP3 is not a sufficient marker to identify Tregs in humans. Several later studies confirmed this. However, there is no published evidence that FoxP3 can be expressed in Teff cells in mice. In a lethal model of oral infection with toxoplasma gondii, a collapse of Treg numbers and increased Apoe −/− mice have been reported to develop reduced atherosclerosis. 26, 32 This finding was attributed to reduced monocyte recruitment, but our data suggest that there is 30 is atheroprotective. Again, in these studies, the protective effect cannot be attributed to reduced T-cell homing because recruitment of inflammatory monocytes is also reduced. 28, 29 Here, we show that half of the CD4 T cells homing into the atherosclerotic aorta require CCR5. In a previous study, we have shown that another smaller subset uses CXCR6 for homing to the aorta. 23 Together, these 2 chemokine-receptor systems, CCR5-CCL5 and CXCR6-CXCL16, explain most T-cell homing to atherosclerotic aortas in mice.
The CCR5Teffs promote atherosclerosis by secreting TNF and IFN-γ, both known proatherogenic cytokines.
9,10,45,46 IFN-γ activates macrophages, 62 inducing and reinforcing the M1 phenotype 63 ) that is known to drive atherosclerosis. 64, 65 The role of TNF in atherosclerosis is less clear, but blocking TNF has been reported to limit atherosclerosis in mice. 45, 46 We have previously shown that TNF is produced when antigen-experienced CD4 T cells are incubated with explanted atherosclerotic aortas. 22 Taken together, the CCR5Teff cells seem to be a significant source of proatherogenic cytokines.
We conclude that CCR5 fulfills a nonredundant, essential role for the homing of CD4 T cells to the atherosclerotic aortic wall where they exacerbate atherosclerosis. This identifies CCR5 and its ligand CCL5 as the most important homing receptor-ligand pair for T cells in atherosclerosis. Almost all CCR5 + T cells are CD4 + CD44 hi CD62L − FoxP3 low IFN-γ + T-bet + CD25 − and thus represent an atherosclerosis-specific subset of T cells that has not been described before in atherosclerosis or in other diseases. Interestingly, these CCR5Teff cells home to and are highly enriched in the atherosclerotic aorta, suggesting they are a local pool of memory T cells. -/-mice were provided by Dr. Catherine Hedrick (La Jolla Institute, USA). All mice were on a C57BL/6 background. At 8 weeks of age, female and male Apoe -/-and B6 mice were fed with WD (TD.88137, Harlan). After 12 weeks to 20 weeks of WD feeding, the mice were used for flow cytometry. Mice were kept in an AAALAC-approved barrier facility under specific pathogen-free conditions. All mice were genotyped using standard PCR protocols (Transnetyx).
Aortic single-cell preparation
Mice were sacrificed by CO 2 , and aortas were perfused with PBS containing heparin (20 U/ml). Aortas or carotid arteries were isolated by removal of all adventitial fat or surrounding muscles, cut into small pieces, and incubated for 50 to 60 minutes at 37°C with gentle shaking in a mixture of 237 U/ml collagenase type I, 190 U/ml collagenase type XI, 120 U/ml hyaluronidase, and 120 U/ml DNase I (all enzymes from Sigma-Aldrich) in HBSS. 
Flow cytometry analysis
Quantification of atherosclerosis, histology and immunofluorescence
Isolated whole aortas were fix with 4% PFA and stained with Sudan IV. Digital images were obtained and analyzed by ImageJ to calculate the percentage of plaque area per aorta. Aortic roots were frozen in OCT compound on dry ice and stored at -80°C. 5-μm sections were taken in the aortic valve plane. Frozen sections were thawed and fixed for 10 minutes in isopropanol on ice. Sections were blocked by 10% normal goat serum (Sigma, G9023-10ML) for 1 hour at room temperature and then stained by rat anti-mouse CCR5-FITC (clone: HEK/1/85a; abcam) and rabbit anti-mouse CD3 (clone: ab5690; abcam), or by rabbit anti-mouse CCL5 (clone R6G9; eBioscience) and rat anti-mouse CD31-APC (clone MEC 13.3; BD Bioscience) over night followed by staining with secondary antibody: anti-FITC Alexa Fluor 488 (Molecular Probes) and anti-rabbit IgG Alexa Flour 650 (Abcam) or by anti-rabbit IgG Alexa Flour 568 (invitrogen). Images were acquired on a Leica DM6000 upright microscope using HCX PLAPO ×20 and ×40 oil-immersion objectives. Co-localization of fluorescence signal from CCR5 and CD3 was analyzed by ImageJ. In order to analyze co-localization, background was substracted from the CD3 and CCR5 channels. Then a CD3 mask channel showing only CD3 positive cells was created. Based on the mask a new CD3 and CCR5 channels which contained signal only within the masked area was created.
Cell sorting
For in vitro T cell homing assay, lymphocytes harvested from spleen were purified by RoboSep CD4 T cell negative selection (StemCell Technology). The effector (CD4 + CD25 -CD44 hi CD62L -) and naïve (CD4 + CD25 -CD44 lo CD62L + ) T cells were stained with anti-mouse CD4 PE (clone rm4-5; Biolegend), anti-mouse CD25 APC (clone PC61.5; eBioscience), anti-mouse CD44 eF450 (clone IM7; eBioscience) and anti-mouse CD62L PE-Cy7 (clone MEL-14; Biolegend) and then sorted on FACSAria (BD Bioscience).
2 photon imaging 2-photon imaging was performed using a DM 6000 upright microscope with 4 nondescanned detectors (Leica Microsystems) and a Chameleon Ultra Ti: Sapphire laser (Coherent) tuned at 900-1,000 nm for acquisition using a water-dipping objective (Olympus XLUMPLFL 20XW, NA0.95). Emitted fluorescence was split with 2 dichroic mirrors (560 nm and 593 nm) and passed through filters (Semrock) at 535/22 nm, 585/40 nm, and 624/40 nm. Typically, 10-20 z planes spaced 10-15 μm apart were acquired at 512 × 512 pixels every 1 minute. Images were smoothed by median filtering at kernel size 3 × 3 pixels. 3D reconstructions of aortas were performed using Imaris software (version 7.1.1 ×64; Bitplane AG) after stitching several z series encompassing the artery using XuvTools software.
Treg suppression assay
To analyze CCR5Teff cell function, we performed a suppression assay with T cells derived from the para- -/-CD mice or without Tregs as controls. After 4 days of culture in complete RPMI 1640 medium containing 10% FBS, penicillin/streptomycin, l-glutamine, NEAA, HEPES, and sodium pyruvate in 96-well round-bottom plates at 37°C and 5% CO2 in a humidified incubator, proliferation was measured by CellTrace Violet signal using flow cytometry, and supernatant was collected to measure cytokine secretion by mouse Th1/Th2/Th17 cytometric bead array (BD Biosciences). hi CD62L lo ) were sorted from pooled paLNs from 5 Apoe -/-on WD for 5 months. RNA was extracted from sorted cells using RNeasy micro kit (Qiagen). RNA quality was determined by bioanalyzer. RNA was reverse transcribed and tagged using the Nextera kit and RNA sequencing is performed on Illumina Hiseq 2500 using rapid run mode following SMARTseq II protocol from Illumina 66 .
In vivo T cell functional assay
RNA sequencing data analysis. The single-end reads that passed Illumina filters were filtered for reads aligning to tRNA, rRNA, adapter sequences, and spike-in controls. The reads were then aligned to UCSC mm9 reference genome using TopHat (v 1.4.1) 67 . DUST scores were calculated with PRINSEQ Lite (v 0.20.3) 68 and low-complexity reads (DUST > 4) were removed from the BAM files. The alignment results were parsed via the SAMtools 69 to generate SAM files. Read counts of each genomic feature were obtained with the htseq-count program (v 0.6.0) 70 using the "union" option. After removing absent features (zero counts in all samples), the raw counts were then imported to R/Bioconductor package DESeq2 71 to identify differentially expressed genes among samples. DESeq2 normalizes counts by dividing each column of the count table (samples) by the size factor of this column. The size factor is calculated by dividing the samples by geometric means of gene counts (nth root of the product of gene counts across samples). This normalizes the counts being averaged, so that no counts dominate the weighting. P-values for differential expression were calculated using binomial test for differences between the base means of two conditions. These p-values were then adjusted for multiple test correction using the Benjamini Hochberg algorithm 72 to control the false discovery rate. We considered genes differentially expressed between two groups of samples when the DESeq2 analysis resulted in an adjusted P-value of <0.01. Cluster analyses including principal component analysis (PCA) and hierarchical clustering were performed using standard algorithms and metrics. Hierarchical clustering was performed using complete linkage with Euclidean metric. The sequences and reads counts used in this article have been submitted to the Gene Expression Omnibus under accession number XXXX (http://www.ncbi.nlm.nih.gov/geo/).
Online Figure I . Digestion process affects surface expression of CD4, CCR5 and CD62L. PaLNs were harvested from Apoe -/-mice fed on WD>5mth. Single cell suspension were split into two tubes. One was digested by enzyme cocktail as described in methods section. The other one was not digested. Cells were analyzed by multi-color flow cytometry. The populations shown in the figure are all gated on live singlets CD45 + cells. 
